Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Experimental & Clinical Cancer Research
Published in: Journal of Experimental & Clinical Cancer Research 1/2011

Open Access 01-12-2011 | Research

A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro

Authors: Wei Sun, Yue Z Fan, Wen Z Zhang, Chun Y Ge

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2011

Login to get access

Abstract

Background

Vasculogenic mimicry (VM), as a new blood supply for tumor growth and hematogenous metastases, has been recently described in highly aggressive human melanoma cells, etc. We previously reported VM in human gallbladder carcinomas and its clinical significance. In this study, we further studied histomorphology and hemodynamic of VM in gallbladder carcinomas in vivo and in vitro.

Methods

The invasive potential of human gallbladder carcinoma cell lines GBC-SD and SGC-996 were identified by Transwell membrane. The vasculogenic-like network structures and the signal intensities i.e. hemodynamic in gallbladder carcinomas stimulated via the three-dimensional matrix of GBC-SD or SGC-996 cells in vitro, the nude mouse xenografts of GBC-SD or SGC-996 cells in vivo were observed by immunohistochemistry (H&E staining and CD31-PAS double staining), electron microscopy and micro-MRA with HAS-Gd-DTPA, respectively.

Results

Highly aggressive GBC-SD or poorly aggressive SGC-996 cells preconditioned by highly aggressive GBC-SD cells could form patterned networks containing hollow matrix channels. 85.7% (6/7) of GBC-SD nude mouse xenografts existed the evidence of VM, 5.7% (17/300) channels contained red blood cells among these tumor cell-lined vasculatures. GBC-SD xenografts showed multiple high-intensity spots similar with the intensity observed at tumor marginal, a result consistent with pathological VM.

Conclusions

VM existed in gallbladder carcinomas by both three-dimensional matrix of highly aggressive GBC-SD or poorly aggressive SGC-996 cells preconditioned by highly aggressive GBC-SD cells in vitro and GBC-SD nude mouse xenografts in vivo.
Appendix
Available only for authorised users
Literature
1.
2.
Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS, Hendrix MJ: Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999, 155: 739-752. 10.1016/S0002-9440(10)65173-5.PubMedCentralCrossRefPubMed
3.
Frenkel S, Barzel I, Levy J, Lin AY, Bartsch DU, Majumdar D, Folberg R, Pe'er J: Demonstrating circulation in vasculogenic mimicry patterns of uveal melanoma by confocal indocyanine green angiography. Eye (Lond). 2008, 22: 948-952.CrossRef
4.
Zhang S, Guo H, Zhang D, Zhang W, Zhao X, Ren Z, Sun B: Microcirculation patterns in different stages of melanoma growth. Oncol Rep. 2006, 15: 15-20.PubMed
5.
6.
Folberg R, Maniotis AJ: Vasculogenic mimicry. APMIS. 2004, 112: 508-525. 10.1111/j.1600-0463.2004.apm11207-0810.x.CrossRefPubMed
7.
Clarijs R, Otte-Holler I, Ruiter DJ, de Waal RM: Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. Invest Ophthalmol Vis Sci. 2002, 43: 912-918.PubMed
8.
Kobayashi H, Shirakawa K, Kawamoto S, Saga T, Sato N, Hiraga A, Watanabe I, Heike Y, Togashi K, Konishi J, et al: Rapid accumulation and internalization of radiolabeled herceptin in an inflammatory breast cancer xenograft with vasculogenic mimicry predicted by the contrast-enhanced dynamic MRI with the macromolecular contrast agent G6-(1B4M-Gd)(256). Cancer Res. 2002, 62: 860-866.PubMed
9.
Shirakawa K, Kobayashi H, Heike Y, Kawamoto S, Brechbiel MW, Kasumi F, Iwanaga T, Konishi F, Terada M, Wakasugi H: Hemodynamics in Vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Research. 2002, 62: 560-566.PubMed
10.
Ruf W, Seftor EA, Petrovan RJ, Weiss RM, Gruman LM, Margaryan NV, Seftor RE, Miyagi Y, Hendrix MJ: Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry. Cancer Res. 2003, 63: 5381-5389.PubMed
11.
Shirakawa K, Kobayashi H, Sobajima J, Hashimoto D, Shimizu A, Wakasugi H: Inflammatory breast cancer: vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model. Breast Cancer Res. 2003, 5: 136-139. 10.1186/bcr585.PubMedCentralCrossRefPubMed
12.
Warso MA, Maniotis AJ, Chen X, Majumdar D, Patel MK, Shilkaitis A, Gupta TK, Folberg R: Prognostic significance of periodic acid-Schiff-positive patterns in primary cutaneous melanoma. Clin Cancer Res. 2001, 7: 473-477.PubMed
13.
Vartanian AA, Stepanova EV, Gutorov SL, Solomko E, Grigorieva IN, Sokolova IN, Baryshnikov AY, Lichinitser MR: Prognostic significance of periodic acid-Schiff-positive patterns in clear cell renal cell carcinoma. Can J Urol. 2009, 16: 4726-4732.PubMed
14.
Shirakawa K, Wakasugi H, Heike Y, Watanabe I, Yamada S, Saito K, Konishi F: Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer. 2002, 99: 821-828. 10.1002/ijc.10423.CrossRefPubMed
15.
Sood AK, Fletcher MS, Zahn CM, Gruman LM, Coffin JE, Seftor EA, Hendrix MJ: The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: implications for anti-vasculogenic therapy. Cancer Biol Ther. 2002, 1: 661-664.CrossRefPubMed
16.
Sun B, Zhang S, Zhang D, Du J, Guo H, Zhao X, Zhang W, Hao X: Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. Oncol Rep. 2006, 16: 693-698.PubMed
17.
Sun BC, Zhang SW, Zhao XL, Hao XS: Vasculogenic mimicry is associated with shorter survival in hepatocellular carcinomas. Laboratory Investigation. 2006, 86: 1302-
18.
Guzman G, Cotler SJ, Lin AY, Maniotis AJ, Folberg R: A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma. Archives of Pathology & Laboratory Medicine. 2007, 131: 1776-1781.
19.
Wang W, Lin P, Han C, Cai W, Zhao X, Sun B: Vasculogenic mimicry contributes to lymph node metastasis of laryngeal squamous cell carcinoma. J Exp Clin Cancer Res. 2010, 29: 60-10.1186/1756-9966-29-60.PubMedCentralCrossRefPubMed
20.
El Hallani S, Boisselier B, Peglion F, Rousseau A, Colin C, Idbaih A, Marie Y, Mokhtari K, Thomas JL, Eichmann A, et al: A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry. Brain. 2010, 133: 973-982. 10.1093/brain/awq044.CrossRefPubMed
21.
Li M, Gu Y, Zhang Z, Zhang S, Zhang D, Saleem AF, Zhao X, Sun B: Vasculogenic mimicry: a new prognostic sign of gastric adenocarcinoma. Pathol Oncol Res. 2010, 16: 259-266. 10.1007/s12253-009-9220-7.CrossRefPubMed
22.
Baeten CI, Hillen F, Pauwels P, de Bruine AP, Baeten CG: Prognostic role of vasculogenic mimicry in colorectal cancer. Dis Colon Rectum. 2009, 52: 2028-2035. 10.1007/DCR.0b013e3181beb4ff.CrossRefPubMed
23.
Sun B, Qie S, Zhang S, Sun T, Zhao X, Gao S, Ni C, Wang X, Liu Y, Zhang L: Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors. Hum Pathol. 2008, 39: 444-451. 10.1016/j.humpath.2007.07.018.CrossRefPubMed
24.
Gourgiotis S, Kocher HM, Solaini L, Yarollahi A, Tsiambas E, Salemis NS: Gallbladder cancer. Am J Surg. 2008, 196: 252-264. 10.1016/j.amjsurg.2007.11.011.CrossRefPubMed
25.
Reddy SK, Clary BM: Surgical management of gallbladder cancer. Surg Oncol Clin N Am. 2009, 18: 307-324. 10.1016/j.soc.2008.12.004.CrossRefPubMed
26.
Hsing AW, Gao YT, Devesa SS, Jin F, Fraumeni JF: Rising incidence of biliary tract cancers in Shanghai, China. Int J Cancer. 1998, 75: 368-370. 10.1002/(SICI)1097-0215(19980130)75:3<368::AID-IJC7>3.0.CO;2-0.CrossRefPubMed
27.
28.
Fan YZ, Sun W, Zhang WZ, Ge CY: Vasculogenic mimicry in human primary gallbladder carcinoma and clinical significance thereof. Zhonghua Yi Xue Za Zhi. 2007, 87: 145-149.PubMed
29.
Liu C, Huang H, Donate F, Dickinson C, Santucci R, El-Sheikh A, Vessella R, Edgington TS: Prostate-specific membrane antigen directed selective thrombotic infarction of tumors. Cancer Res. 2002, 62: 5470-5475.PubMed
30.
Sharma N, Seftor REB, Seftor EA, Gruman LM, Heidger PM, Cohen MB, Lubaroff DM, Hendrix MJC: Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: Role in vasculogenic mimicry. Prostate. 2002, 50: 189-201. 10.1002/pros.10048.CrossRefPubMed
31.
Chung LW, Huang WC, Sung SY, Wu D, Odero-Marah V, Nomura T, Shigemura K, Miyagi T, Seo S, Shi C, et al: Stromal-epithelial interaction in prostate cancer progression. Clin Genitourin Cancer. 2006, 5: 162-170. 10.3816/CGC.2006.n.034.CrossRefPubMed
32.
Fujimoto A, Onodera H, Mori A, Nagayama S, Yonenaga Y, Tachibana T: Tumour plasticity and extravascular circulation in ECV304 human bladder carcinoma cells. Anticancer Res. 2006, 26: 59-69.CrossRefPubMed
33.
Yue WY, Chen ZP: Does vasculogenic mimicry exist in astrocytoma?. J Histochem Cytochem. 2005, 53: 997-1002. 10.1369/jhc.4A6521.2005.CrossRefPubMed
34.
Shevde LA, Metge BJ, Mitra A, Xi Y, Ju J, King JA, Samant RS: Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontin. J Cell Mol Med. 2010, 14: 1693-1706.PubMedCentralCrossRefPubMed
35.
Robertson FM, Simeone AM, Lucci A, McMurray JS, Ghosh S, Cristofanilli M: Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4. Cancer. 2010, 116: 2806-2814. 10.1002/cncr.25167.PubMedCentralCrossRefPubMed
36.
Basu GD, Liang WS, Stephan DA, Wegener LT, Conley CR, Pockaj BA, Mukherjee P: A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells. Breast Cancer Res. 2006, 8: R69-10.1186/bcr1626.PubMedCentralCrossRefPubMed
37.
Hoffmeyer MR, Wall KM, Dharmawardhane SF: In vitro analysis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line. Cancer Cell Int. 2005, 5: 11-10.1186/1475-2867-5-11.PubMedCentralCrossRefPubMed
38.
Shirakawa K, Furuhata S, Watanabe I, Hayase H, Shimizu A, Ikarashi Y, Yoshida T, Terada M, Hashimoto D, Wakasugi H: Induction of vasculogenesis in breast cancer models. Br J Cancer. 2002, 87: 1454-1461. 10.1038/sj.bjc.6600610.PubMedCentralCrossRefPubMed
39.
Hess AR, Seftor EA, Seftor RE, Hendrix MJ: Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res. 2003, 63: 4757-4762.PubMed
40.
Sood AK, Fletcher MS, Hendrix MJ: The embryonic-like properties of aggressive human tumor cells. J Soc Gynecol Investig. 2002, 9: 2-9. 10.1016/S1071-5576(01)00147-2.CrossRefPubMed
41.
Sood AK, Seftor EA, Fletcher MS, Gardner LM, Heidger PM, Buller RE, Seftor RE, Hendrix MJ: Molecular determinants of ovarian cancer plasticity. Am J Pathol. 2001, 158: 1279-1288. 10.1016/S0002-9440(10)64079-5.PubMedCentralCrossRefPubMed
42.
Seftor EA, Meltzer PS, Kirschmann DA, Margaryan NV, Seftor RE, Hendrix MJ: The epigenetic reprogramming of poorly aggressive melanoma cells by a metastatic microenvironment. J Cell Mol Med. 2006, 10: 174-196. 10.1111/j.1582-4934.2006.tb00299.x.PubMedCentralCrossRefPubMed
43.
44.
Petty AP, Garman KL, Winn VD, Spidel CM, Lindsey JS: Overexpression of carcinoma and embryonic cytotrophoblast cell-specific Mig-7 induces invasion and vessel-like structure formation. Am J Pathol. 2007, 170: 1763-1780. 10.2353/ajpath.2007.060969.PubMedCentralCrossRefPubMed
Metadata
Title
A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro
Authors
Wei Sun
Yue Z Fan
Wen Z Zhang
Chun Y Ge
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2011
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/1756-9966-30-46

Other articles of this Issue 1/2011

Journal of Experimental & Clinical Cancer Research 1/2011 Go to the issue

Research

Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I

Research

Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a murin model of peritoneal carcinomatosis

Research

Folic Acid supplementary reduce the incidence of adenocarcinoma in a mouse model of colorectal cancer: microarray gene expression profile

Erratum

Erratum to: A study of association between expression of hOGG1, VDAC1, HK-2 and cervical carcinoma

Retraction Note

Retraction Note: The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma

Research

Clinicopathological characteristics and treatment strategies in early gastric cancer: a retrospective cohort study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits